Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Endocrine 1

Conditions

Carcinoma, Non-Small-Cell Lung 14Lung Neoplasms 5Thymus Neoplasms 2Thymoma 1Thoracic Neoplasms 1Small Cell Lung Carcinoma 1Recurrence 1Mesothelioma, Malignant 1Cardiotoxicity 1Carcinoid Tumor 1Brain Neoplasms 1

Interventions

pembrolizumab 3Quality of Life 2Proton Therapy 2Immunotherapy 2Drug Therapy 2fludarabine 1epacadostat 1bosutinib 1amrubicin 1alovudine 1Tumor Burden 1Sunitinib 1Radiotherapy 1Radiosurgery 1Radiation 1Plicamycin 1Pemetrexed 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Histocompatibility Testing 1Erlotinib Hydrochloride 1Cyclophosphamide 1Blood Specimen Collection 1Biological Therapy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Thymus Neoplasms × Proton Therapy × Thoracic × Clear all
NCT04822077 2021-03-30

PROTHYM

Swedish Lung Cancer Study Group

Phase NA Recruiting
40 enrolled
Thoracic

Thymoma, Thymus Neoplasms, Cardiotoxicity

NCT01165658 2020-01-02

Study of Hypofractionated Proton Radiation Therapy in Thoracic Malignancies

M.D. Anderson Cancer Center

Phase 1 Terminated
30 enrolled
EndocrineThoracic

Carcinoid Tumor, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Thymus Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡